Home › Migraine › California › Fresno
Migraine clinical trials in Fresno, CA
5 studies for Migraine are looking for participants at sites in and around Fresno (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
Study of EVO756 in Adults With Migraine
RecruitingPhase 2
- Neuro Pain Research Center, Fresno
Long-term Safety Study of Rimegepant in Pediatric Subjects for the Acute Treatment of Migraine
RecruitingPhase 3
- Neuro-Pain Research Center, Fresno
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
RecruitingPhase 3
- Neuro-Pain Research Center, Fresno
A Study of Oral Atogepant Tablets to Assess Adverse Events and Change in Disease Activity To Prevent Migraine in Participants Aged 12 to 17 Years
RecruitingPhase 3
- Neuro Pain Research Center /ID# 271048, Fresno
Study to Assess Adverse Events and Disease Activity of Oral Ubrogepant Tablets for the Acute Treatment of Migraine in Children and Adolescents (Ages 6-17)
RecruitingPhase 3
- Neuro Pain Research Center /ID# 227966, Fresno
About Migraine
Migraines are pulsing or throbbing headaches in one area of the head. Learn about other symptoms, what triggers migraines, and how to treat them.
More about Migraine on MedlinePlus
Migraine trials in other cities
- Cincinnati, OH11 studies
- Austin, TX8 studies
- Miami, FL8 studies
- Philadelphia, PA8 studies
- Concord, CA8 studies
- Amherst, NY7 studies
- Omaha, NE7 studies
- Houston, TX7 studies
- Washington, DC7 studies
- Aurora, CO6 studies
- Stamford, CT6 studies
- San Diego, CA6 studies
Other studies in Fresno
- Non-Small Cell Lung Cancer7 studies
- Lung Cancer7 studies
- Breast Cancer6 studies
- Respiratory Distress Syndrome6 studies
- Steatotic Liver Disease5 studies
- Prostate Cancer5 studies
- Acute Myeloid Leukemia5 studies
- Burkitt Lymphoma4 studies
- Cancer (all types)4 studies
- Ovarian Cancer4 studies
- Acute Lung Injury4 studies
- Diabetic Foot3 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.